Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery

NCT06926374 · Chinese University of Hong Kong · Updated 16 April 2025

What is being tested
Robotic surgery using the Sentire Surgical System
For
Colorectal Carcinoma; Rectal Prolapse; Prostate Cancer (Adenocarcinoma); Bladder Cancer; Kidney Cancer; Hiatal Hernia With Gastroesophageal Reflux Disease; GIST - Gastrointestinal Stromal Tumor; Esophageal Cancer; Gallstones; Gastric Cancer
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 80 years. About 90 people. The full rules are on the registry page.
Where
China
When
Starts or started 25 March 2025, ends April 2027. Registered 13 April 2025.
Results
None posted yet.

In the researchers' words

Robotic assisted surgery has been performed for more than two decades with good success and safety profile. However, there was only one dominating robotic surgical system available in the past which led to high cost for robotic surgery. Recently, a new robotic surgical system (Sentire Robotic Surgical System) was introduced by researchers of The Chinese University of Hong Kong (CUHK). This new robotic surgical system aims to achieve similar outcomes and standards of robotic surgery performed using the dominating system but with a significantly lower cost. The technologic innovation and development of this new robotic system is made by the Cornerstone Robotics Limited, which is based in Hong Kong. In a pilot clinical study conducted at Prince of Wales Hospital involving 55 patients, the Sentire Robotic Surgical System had demonstrated high success rate with minimal complications in patients who underwent robotic colorectal, upper gastrointestinal, and urologic surgery. Researchers of CUHK would therefore like to conduct another prospective study to further evaluate the efficacy and safety of Sentire Surgical System C1000 in major gastrointestinal and urologic surgery with expanded indications. It is believed that the results of this study will provide data to support its use for wide range of procedures with minimal access trauma, for the benefit of patients. This system will…
ClinicalTrials.gov, NCT06926374

Sites

  • Prince of Wales Hospital, The Chinese University of Hong KongHong Kong, China